FORE Biotherapeutics vs SurgiAI
FORE Biotherapeutics vs SurgiAI, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: FORE Biotherapeutics is on 56/100 and SurgiAI on 23/100.
Where each one leads
FORE Biotherapeutics
- our overall score: 56/100 against 23/100
- agent readiness: 37/100 against 21/100
SurgiAI
- domain rating: 94/100 against 35/100
At a glance
| Measure | FORE Biotherapeutics | SurgiAI |
|---|---|---|
| What it is | Precision oncology company developing cancer therapies guided by proprietary functional genomics. | AI-powered platform enhancing surgical precision and patient outcomes through data-driven recommendations. |
| Category | Healthcare, Drug Development, Genomics, Next Generation Sequencing | Healthcare, Surgery, Medical Imaging, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2011 | 2023 |
| Headquarters | Philadelphia, United States | Not published |
| Status | Active | Active |
Size, funding and growth
| Measure | FORE Biotherapeutics | SurgiAI |
|---|---|---|
| Employees | 56 | Not published |
| Headcount growthLast 12 months | +8.2% | Not published |
| Total funding | $232M | Not published |
| Latest round | Series D-2 Extension | Grant |
| Valuation | $75.0M | Not published |
| LinkedIn followers | 4,584 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | FORE Biotherapeutics | SurgiAI |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 23/100 |
| Traction | 58/100 | Not published |
| Team | 70/100 | 60/100 |
| Search visibility | 38/100 | 11/100 |
| Quality | 55/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 35/100 | 94/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | FORE Biotherapeutics | SurgiAI |
|---|---|---|
| CDN | Not detected | Fastly |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
FORE Biotherapeutics vs SurgiAI: common questions
Which is better, FORE Biotherapeutics or SurgiAI?
On our 0-100 score FORE Biotherapeutics rates higher (56/100 against 23/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do FORE Biotherapeutics and SurgiAI compare on the numbers?
FORE Biotherapeutics leads on our overall score (56/100 against 23/100), agent readiness (37/100 against 21/100). SurgiAI leads on domain rating (94/100 against 35/100).
Read the full FORE Biotherapeutics review and pricing or the SurgiAI review and pricing. You can also browse other FORE Biotherapeutics alternatives we track.